The Vanguard Group 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Royalty Pharma plc RPRX |
The Vanguard Group | 37,997,522 8.540% |
2,369,731 (+6.65%) |
Filing |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Royalty Pharma plc RPRX |
The Vanguard Group | 35,627,791 8.080% |
5,991,226 (+20.22%) |
Filing |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Royalty Pharma plc RPRX |
The Vanguard Group | 29,636,565 6.900% |
29,636,565 (New Position) |
Filing |